Literature DB >> 7482533

Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient.

R D Palmiter1.   

Abstract

BHK cells were stably transformed with plasmid constructs that allowed constitutive expression of either mouse metallothionein-I (MT-I) or MT-III to determine whether these isoforms have different physiological properties. Cells expressing equivalent amounts of MT-I or MT-III could grow in 60-fold more cadmium than nontransfected cells and they were 2- to 3-fold more resistant to zinc, copper, and cobalt. The results suggest that the two MT isoforms detoxify these metals similarly. MT-III reduced the amount of zinc available to activate a zinc-sensitive reporter gene; MT-I actually increased the expression of the reporter gene at low concentrations of zinc. Cells expressing MT-I or MT-III also responded differently to zinc deficiency. When cells expressing MT-I were deprived of zinc, the amount of MT-I protein declined to undetectable levels, even though MT-I mRNA was still abundant, and cell proliferation was unaffected. In contrast, when cells expressing the MT-III gene were deprived of zinc, cell proliferation was arrested and MT-III protein persisted. These results suggest that MT-I does not compete with essential zinc-requiring proteins and is degraded, whereas MT-III competes for zinc and exacerbates zinc deficiency.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482533     DOI: 10.1006/taap.1995.1216

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  24 in total

1.  CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.

Authors:  M Penkowa; J Carrasco; M Giralt; T Moos; J Hidalgo
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis.

Authors:  M A Sens; S Somji; S H Garrett; C L Beall; D A Sens
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 3.  The elusive function of metallothioneins.

Authors:  R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 4.  Brain injury and growth inhibitory factor (GIF)--a minireview.

Authors:  I Hozumi; T Inuzuka; S Tsuji
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

5.  Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.

Authors:  M A Lovell; J L Smith; S Xiong; W R Markesbery
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 6.  Chemistry and biology of mammalian metallothioneins.

Authors:  Milan Vašák; Gabriele Meloni
Journal:  J Biol Inorg Chem       Date:  2011-06-07       Impact factor: 3.358

7.  ZnT-2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration.

Authors:  R D Palmiter; T B Cole; S D Findley
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

8.  Identification of mouse brain proteins associated with isoform 3 of metallothionein.

Authors:  David W Lahti; John D Hoekman; Abigail M Tokheim; Bruce L Martin; Ian M Armitage
Journal:  Protein Sci       Date:  2005-03-31       Impact factor: 6.725

9.  Effect of alpha-domain substitution on the structure, property and function of human neuronal growth inhibitory factor.

Authors:  Zhi-Chun Ding; Qi Zheng; Bin Cai; Wen-Hao Yu; Xin-Chen Teng; Yang Wang; Guo-Ming Zhou; Hou-Ming Wu; Hong-Zhe Sun; Ming-Jie Zhang; Zhong-Xian Huang
Journal:  J Biol Inorg Chem       Date:  2007-08-22       Impact factor: 3.358

Review 10.  A potential role for alterations of zinc and zinc transport proteins in the progression of Alzheimer's disease.

Authors:  Mark A Lovell
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.